Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Published:2013-01 Issue:9863 Volume:381 Page:303-312
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Grothey Axel,Cutsem Eric Van,Sobrero Alberto,Siena Salvatore,Falcone Alfredo,Ychou Marc,Humblet Yves,Bouché Olivier,Mineur Laurent,Barone Carlo,Adenis Antoine,Tabernero Josep,Yoshino Takayuki,Lenz Heinz-Josef,Goldberg Richard M,Sargent Daniel J,Cihon Frank,Cupit Lisa,Wagner Andrea,Laurent Dirk

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment;Van Cutsem;Ann Oncol,2010

2. An update on the current and emerging targeted agents in metastatic colorectal cancer;Chu;Clin Colorectal Cancer,2012

3. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity;Wilhelm;Int J Cancer,2011

4. Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study;Strumberg;Br J Cancer,2012

5. EORTC QLQ-C30 Scoring Manual,2001

Cited by 2307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Third-line treatment and beyond in metastatic colorectal cancer: What do we have and what can we expect?;Critical Reviews in Oncology/Hematology;2024-10

3. A quartet of cancer stem cell niches in hepatocellular carcinoma;Cytokine & Growth Factor Reviews;2024-10

4. Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial;Annals of Surgical Oncology;2024-09-13

5. Targeted Therapies for Hepatocellular Carcinoma Treatment;Liver Cancer - Multidisciplinary Approach;2024-09-11